Polymer Factory’s SpheriCal® for IM-MS featured in scientific article
In a scientific article published in May 2024, Polymer Factory’s product manager Jens Sommertune has gathered a group of international mass spectrometry and ion mobility scientists to perform a proof-of-concept and suitability study on the use of compounds from Polymer Factory’s SpheriCal® platform to tune and calibrate Ion Mobility Mass Spectrometry (IM-MS) devices.
IM-MS is an emerging analysis technique that allows for characterization and separation of molecules not only by their mass but also another dimension – the so-called collision cross section (CCS). This is of importance in, for example, biomedical research to assess the conformation of a peptide or protein.
This new research shows that the components from Polymer Factory’s SpheriCal® platform provides the user with a wider range of information than currently available calibration standards; our standard can calibrate and tune against both mass and CCS, and the calibration points provided with SpheriCal® span over a much larger “grid” than existing calibrants.
Polymer Factory plan to make SpheriCal® IM-MS commercially available soon.
Find the link to the publication here.
For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com
Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.